Prognostic Impact of Concurrent DNMT3A, FLT3 and NPM1 Gene Mutations in Acute Myeloid Leukemia Patients
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 21 (12) , e960-e969
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemiaBlood, 2012
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid LeukemiaNew England Journal of Medicine, 2012
- An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatmentOncology Reviews, 2012
- Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic ImplicationsJournal of Clinical Oncology, 2011
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNetBlood, 2010
- Dna Hypomethylation In Cancer CellsEpigenomics, 2009
- Epigenetics in cancerCarcinogenesis, 2009
- Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entityHematological Oncology, 2009
- Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)Blood, 2006
- Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemiaBlood, 2005